• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

Access holds EUR 306m final close for second co-investment fund
Access holds EUR 306m final close for second co-investment fund

Paris-headquartered GP surpassed its EUR 300m target for the fund, which plans to make 16 investments

  • Buyout
  • 14 September 2022
Auctus sells PharmaLex to trade for EUR 1.28bn
Auctus sells PharmaLex to trade for EUR 1.28bn

Deal values German pharma services company at 18x EBITDA

  • Healthcare
  • 14 September 2022
Vitruvian starts fundraising for VIP V
Vitruvian starts fundraising for VIP V

New vehicle registered this month; presented to Los Angeles-based LPs

  • Buyout
  • 14 September 2022
Ex-Silverfleet team regroups with DACH-focused GP Sophora
Ex-Silverfleet team regroups with DACH-focused GP Sophora

Newly formed GP is raising capital from its own network with a longer-term goal of bringing in institutional investors

  • Funds
  • 12 September 2022
Magnum sells Miranza to PAI-backed Veonet for EUR 250m
Magnum sells Miranza to PAI-backed Veonet for EUR 250m

Off-market deal values Spanish eye care chain at 14x EBITDA; at least three more ophtha assets in M&A pipeline

  • Southern Europe
  • 12 September 2022
Investindustrial aims for EUR 1bn close with third lower-mid cap fund
Investindustrial aims for EUR 1bn close with third lower-mid cap fund

Lower-mid market strategy has sealed one first investment ahead of expected closing in coming months

  • Buyout
  • 09 September 2022
Duke Street to reap 2.5x-plus money in Medi-Globe sale to trade
Duke Street to reap 2.5x-plus money in Medi-Globe sale to trade

DCC Healthcare to pay EUR 245m for German medical devices group; deal marks GP’s 12th trade exit

  • Exits
  • 09 September 2022
Trill Impact heads for first close of VC fund at year-end
Trill Impact heads for first close of VC fund at year-end

Impact investor has a EUR 300m target for the debut VC fund; new vehicle has completed one deal so far

  • Funds
  • 09 September 2022
Verdane invests in Qbtech, Topro via impact fund
Verdane invests in Qbtech, Topro via impact fund

Privately-owned ADHD test maker and PE-backed mobility device producer are fourth and fifth deals from Verdane Idun I

  • Expansion
  • 02 September 2022
C'est la rentrée: PEs line up French deals despite adverse market
C'est la rentrée: PEs line up French deals despite adverse market

Local economy managed to stay comparatively strong compared to sluggish global growth and inflationary pressures

  • France
  • 01 September 2022
Adelis exits Nordentic to PE-backed Corus
Adelis exits Nordentic to PE-backed Corus

Sale leaves three assets in Adelis 2012 vintage fund; Corus backer CareVentures working on refi for acquisitions

  • Healthcare
  • 31 August 2022
Stirling Square cancels Outcomes First Group sale process
Stirling Square cancels Outcomes First Group sale process

GP expected to switch focus to break-up of UK specialist care and fostering provider

  • Exits
  • 31 August 2022
Foresight reaps 4.1x on Mi Healthcare sale to trade
Foresight reaps 4.1x on Mi Healthcare sale to trade

Exit of UK-based radiology machine services is fourth exit from North-West focused fund

  • Exits
  • 26 August 2022
Ampersand closes USD 1.2bn healthcare fund for US, EU deployment
Ampersand closes USD 1.2bn healthcare fund for US, EU deployment

Fundraise follows hiring push in Europe; GP typically deploys USD 10m-50m tickets in primary buyouts

  • Buyout
  • 24 August 2022
Inflexion gears up for third Partnership Capital fund
Inflexion gears up for third Partnership Capital fund

GPт€™s previous vehicle dedicated to minority investing held a final close in 2018 on GBP 700m

  • Funds
  • 22 August 2022
Adelis raises continuation vehicle for SSI Diagnostica
Adelis raises continuation vehicle for SSI Diagnostica

New fund, with StepStone as lead investor, allows infectious test manufacturer to buy US peer TechLab

  • Secondaries
  • 22 August 2022
Advent, GHO could explore sale of intensive care providers in 12-18 months
Advent, GHO could explore sale of intensive care providers in 12-18 months

Deutsche Fachpflege and Linimed expected to hit German auction pipeline; advisers yet to be appointed

  • Exits
  • 22 August 2022
The Bolt-Ons Digest - 19 August 2022
The Bolt-Ons Digest - 19 August 2022

Unquoteт€™s selection of the latest add-ons with Apax's Groupe Crystal, Livingbridge's CitNOW, Tritonт€™s Fertiberia and more

  • Buyouts
  • 19 August 2022
Doxx owner pulls process despite solid bids from private equity players
Doxx owner pulls process despite solid bids from private equity players

Alantra-led sale process for the German healthcare staffing platform had lasted around six months

  • Buyouts
  • 18 August 2022
Aurelius exits Transform Hospital Group to Y1 Capital
Aurelius exits Transform Hospital Group to Y1 Capital

Buyer adds cosmetic surgery chain to portfolio of healthcare assets; is targeting IPO on Nordic Growth markets

  • Healthcare
  • 17 August 2022
Geneo to hold final close for mezzanine impact fund by year-end
Geneo to hold final close for mezzanine impact fund by year-end

Evergreen sponsor has set EUR 200m target for the fund, which will focus on European companies

  • Mezzanine
  • 15 August 2022
Inflexion sells Pharmaspectra to IQVIA for USD 100m
Inflexion sells Pharmaspectra to IQVIA for USD 100m

Exit of medical data disseminator generates 25% IRR after three years of ownership

  • Healthcare
  • 12 August 2022
ArchiMed reaps 4x on Bomi sale to UPS
ArchiMed reaps 4x on Bomi sale to UPS

Deal is first full exit from specialist healthcare investor's maiden mid-market fund

  • Southern Europe
  • 09 August 2022
GP Profile: Greenpeak Partners on emerging manager fundraising and specialisation
GP Profile: Greenpeak Partners on emerging manager fundraising and specialisation

Buy-and-build specialist looks for portfolio add-ons as it contemplates hitting the road for a new fund in 2023

  • GPs
  • 08 August 2022
789
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013